A major new study investigating the safest and most effective way to monitor blood sugar levels during labour in women with gestational diabetes has ...

Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the ...

Join us in Minneapolis to hear more from keynote speaker Lisa Earnhardt, at DeviceTalks Minnesota on May 4, 2026.

Glucotrack (Nasdaq:GCTK) today provided an update on the planned regulatory timeline for its continuous blood glucose monitor ...

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today provided a ...

Advances in microfluidic biosensors and materials science transformed sweat into a reliable, high-quality data stream capable ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can ...

Chronic disease management stands at an inflection point. Globally, the number of people living with diabetes continues to climb, and healthcare systems in both developed and emerging markets are ...

Abbott Laboratories (NYSE:ABT) ranks among the best most active stocks to buy right now. Following encouraging results from ...

In December 2025, the Company reported that sunRIZE demonstrated reductions from baseline in hypoglycemia events, but the study did not meet its primary endpoint because the reductions were not ...

According to the in-depth market research report published by MarkNtel Advisors, the Wearable Health Devices Market in GCC is projected to grow at a CAGR of around 14.7% during 2026–2032, reflecting ...